Clear Street’s KALA BIO KALA Stock Holding History

Clear Street’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-988	Closed	-$1.88M	–	1227
2022 Q4	$1.88M	Buy	+988	New	+$391K	0.02%	63

Other funds holding KALA

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

KOCAA

Knights of Columbus Asset Advisors New Haven, Connecticut $2B AUM 42.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Clear Street's KALA Position: Q1 2023 in Review

Clear Street sold out of KALA BIO (KALA) in Q1 2023, closing a stake of 988 shares — an estimated $1.88M sold.

Clear Street first reported a position in KALA in Q4 2022 and held it in 1 quarter. The position peaked at $1.88M in Q4 2022. 21 funds tracked by Wall St. Rank hold KALA as of Q1 2023.

Clear Street reported no remaining KALA BIO position as of Q1 2023 after selling out during the quarter.
Clear Street sold 988 KALA BIO shares in Q1 2023, an estimated $1.88M.
Clear Street first reported a position in KALA BIO in Q4 2022 and held it in 1 quarter.
Clear Street's KALA BIO position peaked at $1.88M in Q4 2022.
21 funds tracked by Wall St. Rank held KALA BIO as of Q1 2023.

Based on Clear Street's 13F filing for Q1 2023, filed 12 May 2023.